TECHNOPHAGE, a biotechnology company headquartered in Lisbon, Portugal, announced today that the company has received authorization from U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for TP-102, a bacteriophage cocktail for...
New patent granted to TechnoPhage: Title: Antibacterial Phage, Phage Peptides and Methods Of Use Thereof Office: The Registry of Patents Singapore Date: 17/7/2014 Patent no: 173533
TECHNOPHAGE and SIMM, SHANGHAI INSTITUTE OF MATERIA MEDICA, a state-owned Institute administered and existing under the laws of the People’s Republic of China, have signed today a collaboration agreement for the joint development of a new pharmaceutical drug,...
TECHNOPHAGE and UNIVERSITY OF MACAU, a University administered and existing under the laws of Macau Special Administrative Region, China, have signed today a Statement of Work relating to the development of new therapeutics directed at ageing-related diseases,...
